This one day meeting, co-hosted by the BTS Mechanistic and Discovery Toxicology subsection, will highlight state of the art and evolving safety assessment strategies in Discovery and early Development Safety Assessment. Particular focus will be on approaches for assessing renal, cardiovascular, gastrointestinal and bone marrow toxicity, alongside emerging areas of science such as the microbiome, immunological reactions, and immune therapy. This is an interactive meeting with plenty of opportunity for discussion and networking.
Keynote 1: Dean Naisbitt, CDSS, Liverpool ‘Patient susceptibility to immunological drug reactions – Early screening opportunities’
Keynote 2: Mike Chapman, MRC Toxicology Unit, Cambridge ‘ Understanding and Mediating the Toxicity of Car-T Therapy’
Meeting Programme: To follow
Meeting flyer: To follow
Registration (free): CLICK HERE